Affobis 1.25 Tablet
Marketer
Medicamen Lifesciences Pvt Ltd
Salt Composition
Bisoprolol (1.25mg)
Overview Affobis 1.25 Tablet
Cardoxin 1.25mg tablets are classified as beta-adrenergic blocking agents. They're indicated for managing hypertension, angina pectoris (chest discomfort stemming from heart issues), and cardiac arrhythmias. This medication also contributes to the prevention of future myocardial infarctions. Cardoxin 1.25mg is further employed to alleviate hyperthyroidism symptoms. It can be administered independently or in conjunction with other therapies. Dosage and frequency are determined by the specific condition and its severity. Administration may be irrespective of meals, yet consistent daily timing is crucial for optimal efficacy. Full therapeutic effects may take several weeks to manifest, and lifelong use might be necessary. Continued use is vital even in the absence of symptoms, as hypertension often presents asymptomatically, and cessation may exacerbate the condition. Common adverse effects include lassitude, cephalgia, bradycardia, vertigo, and nausea; these are generally transient and mild. Respiratory compromise or hypotension may occur in some individuals. To minimize adverse events, initiation is typically at a low dosage with gradual titration. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any hepatic impairment to your doctor. This medication may be unsuitable for patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals should seek medical counsel before use. Regular blood pressure monitoring is essential to gauge therapeutic response. Alcohol consumption should be avoided due to the potential for amplified side effects.
Uses of Affobis 1.25 Tablet
Managing high blood pressure | Alleviating angina pectoris | Addressing cardiac arrhythmias | Reducing heart attack risk
Major Benefits of Affobis 1.25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Affobis 1.25 Tablet whole; do not break, crush, or chew it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Affobis 1.25 Tablet:
- Nausea
- Headache
- Slow heart rate
- Fatigue
- Constipation
- Diarrhea
- Dizziness
- Cold extremities
How to use Affobis 1.25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Affobis 1.25 Tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Affobis 1.25 Tablet works:
Cardioslow 1.25mg tablets are a cardioselective beta-adrenergic blocking agent, targeting the heart to reduce heart rate and improve the efficiency of blood circulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Affobis 1.25 Tablet and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Affobis 1.25 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Affobis 1.25 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Affobis 1.25 Tablet.
KidneyCAUTION
Patients with kidney impairment should use Affobis 1.25mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Routine blood pressure checks are advised to guide appropriate dosage.
LiverCAUTION
Patients with hepatic impairment should use Affobis 1.25 mg tablets cautiously, potentially requiring dosage modification. Close medical supervision is advised, beginning with a reduced initial dose and gradually increasing it under careful monitoring.
What if you forget to take Affobis 1.25 Tablet :
Should you forget a dose of Affobis 1.25 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Affobis 1.25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzyl ether derivative |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Cardioselective beta-blocker |



